Cargando…
Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study
Background: Herpes simplex 1 co-infections in patients with COVID-19 are considered relatively uncommon; some reports on re-activations in patients in intensive-care units were published. The aim of the study was to analyze herpetic re-activations and their clinical manifestations in hospitalized CO...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465957/ https://www.ncbi.nlm.nih.gov/pubmed/34576791 http://dx.doi.org/10.3390/microorganisms9091896 |
_version_ | 1784573008920182784 |
---|---|
author | Franceschini, Erica Cozzi-Lepri, Alessandro Santoro, Antonella Bacca, Erica Lancellotti, Guido Menozzi, Marianna Gennari, William Meschiari, Marianna Bedini, Andrea Orlando, Gabriella Puzzolante, Cinzia Digaetano, Margherita Milic, Jovana Codeluppi, Mauro Pecorari, Monica Carli, Federica Cuomo, Gianluca Alfano, Gaetano Corradi, Luca Tonelli, Roberto De Maria, Nicola Busani, Stefano Biagioni, Emanuela Coloretti, Irene Guaraldi, Giovanni Sarti, Mario Luppi, Mario Clini, Enrico Girardis, Massimo Gyssens, Inge C. Mussini, Cristina |
author_facet | Franceschini, Erica Cozzi-Lepri, Alessandro Santoro, Antonella Bacca, Erica Lancellotti, Guido Menozzi, Marianna Gennari, William Meschiari, Marianna Bedini, Andrea Orlando, Gabriella Puzzolante, Cinzia Digaetano, Margherita Milic, Jovana Codeluppi, Mauro Pecorari, Monica Carli, Federica Cuomo, Gianluca Alfano, Gaetano Corradi, Luca Tonelli, Roberto De Maria, Nicola Busani, Stefano Biagioni, Emanuela Coloretti, Irene Guaraldi, Giovanni Sarti, Mario Luppi, Mario Clini, Enrico Girardis, Massimo Gyssens, Inge C. Mussini, Cristina |
author_sort | Franceschini, Erica |
collection | PubMed |
description | Background: Herpes simplex 1 co-infections in patients with COVID-19 are considered relatively uncommon; some reports on re-activations in patients in intensive-care units were published. The aim of the study was to analyze herpetic re-activations and their clinical manifestations in hospitalized COVID-19 patients, performing HSV-1 PCR on plasma twice a week. Methods: we conducted a prospective, observational, single-center study involving 70 consecutive patients with severe/critical SARS-CoV-2 pneumonia tested for HSV-1 hospitalized at Azienda Ospedaliero-Universitaria of Modena. Results: of these 70 patients, 21 (30.0%) showed detectable viremia and 13 (62%) had clinically relevant manifestations of HSV-1 infection corresponding to 15 events (4 pneumonia, 5 herpes labialis, 3 gingivostomatitis, one encephalitis and two hepatitis). HSV-1 positive patients were more frequently treated with steroids than HSV-1 negative patients (76.2% vs. 49.0%, p = 0.036) and more often underwent mechanical ventilation (IMV) (57.1% vs. 22.4%, p = 0.005). In the unadjusted logistic regression analysis, steroid treatment, IMV, and higher LDH were significantly associated with an increased risk of HSV1 re-activation (odds ratio 3.33, 4.61, and 16.9, respectively). The association with the use of steroids was even stronger after controlling for previous use of both tocilizumab and IMV (OR = 5.13, 95% CI:1.36–19.32, p = 0.016). The effect size was larger when restricting to participants who were treated with high doses of steroids while there was no evidence to support an association with the use of tocilizumab Conclusions: our study shows a high incidence of HSV-1 re-activation both virologically and clinically in patients with SARS-CoV-2 severe pneumonia, especially in those treated with steroids. |
format | Online Article Text |
id | pubmed-8465957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84659572021-09-27 Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study Franceschini, Erica Cozzi-Lepri, Alessandro Santoro, Antonella Bacca, Erica Lancellotti, Guido Menozzi, Marianna Gennari, William Meschiari, Marianna Bedini, Andrea Orlando, Gabriella Puzzolante, Cinzia Digaetano, Margherita Milic, Jovana Codeluppi, Mauro Pecorari, Monica Carli, Federica Cuomo, Gianluca Alfano, Gaetano Corradi, Luca Tonelli, Roberto De Maria, Nicola Busani, Stefano Biagioni, Emanuela Coloretti, Irene Guaraldi, Giovanni Sarti, Mario Luppi, Mario Clini, Enrico Girardis, Massimo Gyssens, Inge C. Mussini, Cristina Microorganisms Article Background: Herpes simplex 1 co-infections in patients with COVID-19 are considered relatively uncommon; some reports on re-activations in patients in intensive-care units were published. The aim of the study was to analyze herpetic re-activations and their clinical manifestations in hospitalized COVID-19 patients, performing HSV-1 PCR on plasma twice a week. Methods: we conducted a prospective, observational, single-center study involving 70 consecutive patients with severe/critical SARS-CoV-2 pneumonia tested for HSV-1 hospitalized at Azienda Ospedaliero-Universitaria of Modena. Results: of these 70 patients, 21 (30.0%) showed detectable viremia and 13 (62%) had clinically relevant manifestations of HSV-1 infection corresponding to 15 events (4 pneumonia, 5 herpes labialis, 3 gingivostomatitis, one encephalitis and two hepatitis). HSV-1 positive patients were more frequently treated with steroids than HSV-1 negative patients (76.2% vs. 49.0%, p = 0.036) and more often underwent mechanical ventilation (IMV) (57.1% vs. 22.4%, p = 0.005). In the unadjusted logistic regression analysis, steroid treatment, IMV, and higher LDH were significantly associated with an increased risk of HSV1 re-activation (odds ratio 3.33, 4.61, and 16.9, respectively). The association with the use of steroids was even stronger after controlling for previous use of both tocilizumab and IMV (OR = 5.13, 95% CI:1.36–19.32, p = 0.016). The effect size was larger when restricting to participants who were treated with high doses of steroids while there was no evidence to support an association with the use of tocilizumab Conclusions: our study shows a high incidence of HSV-1 re-activation both virologically and clinically in patients with SARS-CoV-2 severe pneumonia, especially in those treated with steroids. MDPI 2021-09-07 /pmc/articles/PMC8465957/ /pubmed/34576791 http://dx.doi.org/10.3390/microorganisms9091896 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Franceschini, Erica Cozzi-Lepri, Alessandro Santoro, Antonella Bacca, Erica Lancellotti, Guido Menozzi, Marianna Gennari, William Meschiari, Marianna Bedini, Andrea Orlando, Gabriella Puzzolante, Cinzia Digaetano, Margherita Milic, Jovana Codeluppi, Mauro Pecorari, Monica Carli, Federica Cuomo, Gianluca Alfano, Gaetano Corradi, Luca Tonelli, Roberto De Maria, Nicola Busani, Stefano Biagioni, Emanuela Coloretti, Irene Guaraldi, Giovanni Sarti, Mario Luppi, Mario Clini, Enrico Girardis, Massimo Gyssens, Inge C. Mussini, Cristina Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study |
title | Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study |
title_full | Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study |
title_fullStr | Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study |
title_full_unstemmed | Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study |
title_short | Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study |
title_sort | herpes simplex virus re-activation in patients with sars-cov-2 pneumonia: a prospective, observational study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465957/ https://www.ncbi.nlm.nih.gov/pubmed/34576791 http://dx.doi.org/10.3390/microorganisms9091896 |
work_keys_str_mv | AT franceschinierica herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT cozzileprialessandro herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT santoroantonella herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT baccaerica herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT lancellottiguido herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT menozzimarianna herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT gennariwilliam herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT meschiarimarianna herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT bediniandrea herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT orlandogabriella herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT puzzolantecinzia herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT digaetanomargherita herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT milicjovana herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT codeluppimauro herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT pecorarimonica herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT carlifederica herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT cuomogianluca herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT alfanogaetano herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT corradiluca herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT tonelliroberto herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT demarianicola herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT busanistefano herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT biagioniemanuela herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT colorettiirene herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT guaraldigiovanni herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT sartimario herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT luppimario herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT clinienrico herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT girardismassimo herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT gyssensingec herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy AT mussinicristina herpessimplexvirusreactivationinpatientswithsarscov2pneumoniaaprospectiveobservationalstudy |